alexa
Reach Us +44-1625-708989
What is the Risk of Suicidality in Depressive Adult Patients Using SSRIs? A Meta-Analysis of RCTs | OMICS International | Abstract
ISSN: 2572-0791

Clinical Depression
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

What is the Risk of Suicidality in Depressive Adult Patients Using SSRIs? A Meta-Analysis of RCTs

Al-Mutawa N*, Andriotti T and Elmahdi H

Consultant Family Medicine, PHCC, Qatar

*Corresponding Author:
Al-Mutawa N
Consultant Family Medicine
PHCC, Qatar
Tel: +97466676000
E-mail: [email protected]

Received Date: February 06, 2017; Accepted Date: February 09, 2017; Published Date: February 16, 2017

Citation: Al-Mutawa N, Andriotti T, Elmahdi H (2017) What is the Risk of Suicidality in Depressive Adult Patients Using SSRIs? A Meta-Analysis of RCTs. Clin Depress 3:121. doi:10.4172/2572-0791.1000121

Copyright: © 2017 Al-Mutawa N, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License; which permits unrestricted use; distribution; and reproduction in any medium; provided the original author and source are credited.

Abstract

Introduction: Selective Serotonin Reuptake Inhibitors (SSRIs) are among the most commonly prescribed medications particularly for patients with depressive disorders. Concerns related to increase risk of suicidality associated with the use of SSRIs were raised since early 1990s. Recent studies show inconclusive and conflicting results about this association. Meta-analysis based on Randomized Controlled Trials (RCTs) in depressive disorders has not been done recently.
Objective: To establish whether there is increased risk of suicidality with the use of SSRIs compared to placebo in the treatment of depressive disorders in adults.
Method and design: Meta-analysis of Randomized Controlled Trials (RCTs).
Data sources: I searched for relevant systematic reviews and RCTs in Medline and Cochrane library database. I checked reference lists of included trials. I included trials from Jan 2000 to September 2016.
Selection criteria: Published systematic reviews of randomised controlled trials comparing SSRIs with placebo in adults diagnosed with a depressive disorder were eligible for inclusion.
Data collection and analysis: One review author selected the trials, assessed their quality. I use random effect meta-analysis. I used Odds Ratio (OR) to summarize dichotomous outcomes.
Results: In the 5 studies identified, 556 suicidal events were detected in 71628 patients treated with SSRI for depressive or other disorders. Pooled OR=0.97(95%CI 0.85-1.1).
Conclusion: These findings support that there is no increased risk of suicidality in adult patients treated with SSRI for depression.

Keywords

Recommended Conferences

8th World Congress on Depression and Anxiety

Tokyo, Japan
Share This Page
Top